Drugs / MODIFIED FOLFOX6
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02142322 | Jun 2004 → Jun 2011 | gastric cancer | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MODIFIED FOLFOX6 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02142322 ↗ |
| Route | Intravenous | “oxaliplatin 100 mg/m2 and FA 100 mg/m2 given as a 2 hour intravenous infusion” NCT02142322 ↗ |